Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Alopecia and Intellectual disability; and very common findings: Delayed speech and language development. 14 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 5 | Delayed speech and language development, Seizure, Autistic behavior |
LSS encodes lanosterol synthase (732 aa). Key enzyme in the cholesterol biosynthesis pathway. Catalyzes the cyclization of (S)-2,3 oxidosqualene to lanosterol, a reaction that forms the sterol nucleus. Highest expression in Brain Spinal cord cervical c-1 (93.6 TPM) and Pituitary (81.3 TPM).
Alopecia-intellectual disability syndrome 4 is associated with mutations in the LSS gene on chromosome 21.
The LSS protein participates in Expression of Lanosterol Synthase (LSS), Squalene 2,3-epoxide cyclizes, forming lanosterol, and SREBP1A,2:LSS gene pathways.
LSS is classified as a druggable target (Druggable Genome and Enzyme categories) with score 0.0.
Genetic testing for LSS is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 2 always present features, 1 very common feature, 3 common features.
No clinical trials have been registered for alopecia-intellectual disability syndrome 4.
5 publications have been identified in PubMed for alopecia-intellectual disability syndrome 4. Research spans Case Report / Case Series (60%), Review / Meta-Analysis (20%), and Basic Science / Preclinical (20%).
Chen Y (2025). [PMID: 39436000](https://pubmed.ncbi.nlm.nih.gov/39436000/). *The Journal of dermatology*. [Case Report / Case Series]
Zhang Y (2025). [PMID: 40696433](https://pubmed.ncbi.nlm.nih.gov/40696433/). *Human genomics*. [Review / Meta-Analysis]
Liu H (2025). [PMID: 40495707](https://pubmed.ncbi.nlm.nih.gov/40495707/). *The Journal of dermatology*. [Case Report / Case Series]
Bao L (2025). [PMID: 40364812](https://pubmed.ncbi.nlm.nih.gov/40364812/). *Frontiers in pediatrics*. [Case Report / Case Series]
Kang Q (2024). [PMID: 38800572](https://pubmed.ncbi.nlm.nih.gov/38800572/). *Frontiers in neuroscience*. [Basic Science / Preclinical]
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 4:50 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Common questions about alopecia-intellectual disability syndrome 4
Skin
2 |
Alopecia, Dry, scaly skin (ichthyosis) |
Head and neck | 1 | Microcephaly |
Age of onset: newborn period.